本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

283.92
-0.5500-0.19%
成交量:1.91萬
成交額:545.66萬
市值:56.60億
市盈率:29.24
高:287.14
開:284.93
低:283.83
收:284.47
52周最高:326.63
52周最低:161.82
股本:1,993.56萬
流通股本:1,935.39萬
量比:0.53
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
淨資產收益率:21.96%
總資產收益率:3.99%
市淨率:5.85
市盈率(LYR):46.32

資料載入中...

2021/07/14

重要事件披露

8-K - Current report
2021/06/07

重要事件披露

8-K - Current report
2021/05/07

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/06

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03

重要事件披露

8-K - Current report
2021/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/01/28

重要事件披露

8-K - Current report
2021/01/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/01/27

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals